Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer

Cancer Treatment Reports

Volumn 70, Issue 7, 1986, Pages 909-910

  de Besi, P ^a   Sileni, V C ^a   Salvagno, L ^a   Tremolada, C ^b   Cartei, G ^b   Fosser, V ^b   Paccagnella, A ^b   Peracchia, A ^b   Fiorentino, M ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CISPLATIN; FLUOROURACIL;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CANCER COMBINATION CHEMOTHERAPY; CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; ESOPHAGUS; ESOPHAGUS CANCER; GASTROINTESTINAL TOXICITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LIVER TOXICITY; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THERAPY; VOMITING;

ADULT; AGED; ALLOPURINOL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG EVALUATION; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE;

EID: 0022444719     PISSN: 03615960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)